Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3015401	pf-amyl	u/l (u/l)	322	405	0.00%
3015401	pf-amyl	— (—)	148	170	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other diseases of pleura

282

110

22.73

307.65

1.4

1.2

81.79

827.90

u/l

0.79

225

Pleural effusion

178

42.47

297.11

1.4

1.1

82.31

1177.52

u/l

0.52

151

Other pleural conditions

150

59.70

268.68

1.4

1.1

60.55

2219.36

u/l

0.53

126

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

203

182

7.63

120.29

1.3

1.2

99.55

225.24

u/l

0.35

144

136

Bacterial pneumoniae

134

110

10.80

116.35

1.3

1.2

43.71

304.64

u/l

0.51

All pneumoniae

201

181

7.44

115.63

1.3

1.2

99.64

226.55

u/l

0.36

144

135

Bacterial pneumonia, not elsewhere classified

133

109

10.80

115.46

1.3

1.2

43.71

307.98

u/l

0.51

Pneumonias (Asthma/COPD co-morbidities)

200

182

7.39

114.80

1.3

1.2

100.00

225.24

u/l

0.35

143

136

Heart failure, not strict

175

150

7.95

106.80

1.3

1.2

56.88

280.68

u/l

0.65

121

120

Influenza and pneumonia

193

176

6.99

103.00

1.3

1.2

102.58

228.05

u/l

0.35

139

134

Heart failure,strict

146

118

8.77

97.64

1.4

1.2

340.60

339.66

u/l

0.00

Pneumonia, organism unspecified

173

175

6.95

96.55

1.3

1.2

304.41

229.47

u/l

0.11

129

133

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

180

152

7.19

95.74

1.3

1.2

105.27

245.95

u/l

0.34

131

116

180

152

7.19

95.74

1.3

1.2

105.27

245.95

u/l

0.34

131

116

Other medical care

130

147

7.99

91.65

1.4

1.2

303.61

331.92

u/l

0.03

101

100

Heart failure, strict

166

186

6.32

85.62

1.3

1.2

309.40

238.13

u/l

0.09

100

148

Any death

155

166

6.71

84.91

1.3

1.2

306.43

255.50

u/l

0.07

120

113

All-cause Heart Failure

163

183

6.32

84.03

1.3

1.2

312.33

242.29

u/l

0.09

145

Bacterial pneumonia (organism specified)

137

186

6.71

83.41

1.3

1.2

43.22

428.55

u/l

0.95

139

Dyspnoea

174

253

5.09

74.19

1.4

1.2

241.74

218.25

u/l

0.04

129

177

Other bacterial diseases

171

222

5.19

71.49

1.3

1.2

466.64

88.04

u/l

0.75

120

161

Other pulmonary diagnosis

100

14.76

71.00

1.3

1.1

123.70

1347.35

u/l

0.46

Persons encountering health services for specific procedures and health care

168

185

5.45

70.15

1.3

1.2

46.02

298.93

u/l

0.82

125

127

Asthma, unspecified (mode), excluding more controls

27.63

70.00

1.3

1.1

94.94

2277.30

u/l

—

COPD differential diagnosis

14.90

69.84

1.3

1.1

121.90

1430.25

u/l

0.46

ILD differential diagnosis

14.90

69.84

1.3

1.1

121.90

1430.25

u/l

0.46

Excluding asthma or asthma-COPD overlap

14.46

69.02

1.3

1.1

121.90

1347.35

u/l

0.46

Bacterial Sepsis

125

180

5.96

66.42

1.3

61.08

390.20

u/l

0.74

135

Implicit bacterial Sepsis

118

171

6.14

65.55

1.3

63.66

409.94

u/l

0.73

128

Suppurative and necrotic conditions of lower respiratory tract

17.49

64.51

1.7

1.1

50.16

21.30

u/l

0.76

Bacterial infection, other or unspecified

127

191

5.64

63.63

1.4

1.2

327.66

72.84

u/l

0.47

135

Bacterial infection, other or unspecified

122

184

5.77

63.23

1.4

1.2

344.25

67.29

u/l

0.49

128

Septicaemia

107

161

6.24

61.72

1.2

108.80

66.14

u/l

0.36

112

Other septicaemia

101

149

6.55

61.66

1.2

111.91

68.50

u/l

0.34

104

Implicit bacterial Sepsis

119

179

5.76

61.46

1.3

63.66

392.97

u/l

0.73

134

Pyothorax

19.32

59.80

1.7

1.1

51.87

17.26

u/l

0.80

Asthma (only as main-diagnosis), excluding more controls

22.22

59.63

1.3

1.2

47.14

2073.82

u/l

0.49

COPD (mode)

16.64

58.38

1.1

53.69

1900.42

u/l

0.49

Renal tubulo-interstitial diseases

157

261

4.49

58.33

1.3

1.2

66.73

316.71

u/l

0.84

198

Asthma, unspecified (mode)

14.38

56.81

1.3

1.1

92.24

1523.00

u/l

0.47

Other bacterial diseases

157

216

4.62

56.64

1.4

1.2

266.84

88.76

u/l

0.44

114

158

Explicit Sepsis

106

177

5.61

54.93

1.2

1.3

109.97

392.89

u/l

0.58

134

Heart failure and antihypertensive medication

12.59

54.89

1.3

49.43

1062.58

u/l

0.59

Care involving use of rehabilitation procedures

105

178

5.44

52.39

1.3

1.2

424.07

310.18

u/l

0.11

122

Asthma, excluding more controls

19.65

51.86

1.3

1.2

94.93

2073.82

u/l

0.47

Heart failure and coronary heart disease

118

158

5.31

51.77

1.4

1.2

50.21

505.28

u/l

0.91

114

Implicit Sepsis

136

226

4.55

51.63

1.2

1.3

81.40

332.10

u/l

0.68

169

Renal failure

120

229

4.65

49.45

1.4

1.2

70.74

342.99

u/l

0.78

173

Other heart diseases

12.29

48.70

1.3

48.86

169.48

u/l

0.59

Asthma (only as main-diagnosis)

11.94

48.66

1.4

1.1

47.08

1430.25

u/l

0.49

Malignant neoplasm of respiratory system and intrathoracic organs

8.50

48.54

1.2

1.3

122.60

519.87

u/l

0.37

Abnormalities of breathing

131

160

4.76

47.15

1.3

1.2

51.19

115.40

u/l

0.95

100

119

Oxycodone

166

5.30

46.85

1.4

1.2

458.41

68.85

u/l

0.60

120

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

8.96

46.27

1.3

108.13

519.29

u/l

0.39

Other heart diseases, wide

113

134

5.16

45.29

1.2

40.39

321.52

u/l

0.80

112

Asthma

11.13

45.28

1.3

1.1

88.61

1430.25

u/l

0.47

Asthma (mode)

11.05

44.43

1.3

1.1

99.25

1430.25

u/l

0.47

Implicit Sepsis

131

232

4.13

43.84

1.3

81.65

339.43

u/l

0.73

174

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

150

280

3.70

42.50

1.4

1.3

143.65

279.49

u/l

0.38

209

Later onset COPD, excluding more controls

14.80

40.28

1.2

1.1

61.45

2426.67

u/l

—

All kidney diseases

139

256

3.72

39.53

1.3

71.38

202.73

u/l

0.59

196

Liquid cancers, helper endpoint

122

5.59

39.38

1.3

33.29

304.81

u/l

0.51

Non-ischemic cardiomyopathy

6.26

39.24

1.3

1.2

689.23

401.12

u/l

0.17

Diseases of the respiratory system

8.69

38.84

1.3

1.1

76.13

969.04

u/l

0.48

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

123

293

3.76

38.82

1.3

1.2

65.76

306.80

u/l

0.84

204

Atrial fibrillation and flutter

11.80

37.52

1.3

1.1

25.52

213.93

u/l

0.78

Dialysis, with operation codes

8.23

37.18

1.6

1.1

37.71

514.34

u/l

0.49

Non-rheumatic valve diseases

5.85

37.11

1.4

1.2

47.71

395.97

u/l

0.67

All chronic kidney diseases

105

206

4.18

37.09

1.3

1.2

473.27

219.25

u/l

0.24

157

Condition for Implicit Sepsis (Organ dysfunction codes)

124

230

3.81

36.94

1.3

82.45

343.14

u/l

0.73

172

Chronic kidney disease

171

4.78

36.69

1.4

1.2

34.43

425.68

u/l

0.90

131

Cardiac arrhythmias

6.25

36.64

1.3

26.24

85.44

u/l

0.77

Atrial fibrillation and flutter with reimbursement

12.49

36.61

1.2

25.18

247.15

u/l

0.78

Diseases of arteries, arterioles and capillaries (FINNGEN)

12.98

36.04

1.2

35.41

247.15

u/l

0.73

COPD/asthma/ILD related infections

125

152

4.12

35.93

1.3

1.2

93.56

245.95

u/l

0.37

116

COPD/asthma related infections

125

152

4.12

35.93

1.3

1.2

93.56

245.95

u/l

0.37

116

Valvular heart disease excluding rheumatic fever

5.71

35.84

1.4

1.2

47.71

395.97

u/l

0.67

Heart failure and bmi 25plus

102

5.38

35.43

1.4

1.2

74.62

81.58

u/l

0.06

Presence of cardiac and vascular implants and grafts

177

4.17

33.78

1.4

1.2

39.30

273.20

u/l

0.73

125

Erysipelas

194

4.20

33.66

1.4

1.2

794.30

71.85

u/l

0.78

138

Abnormal findings on diagnostic imaging of lung

101

254

3.82

33.28

1.2

1.3

70.63

344.90

u/l

0.82

176

Nephropathy related operations

7.60

32.67

1.6

1.2

38.64

558.52

u/l

0.56

Conduction disorders

6.60

32.21

1.3

1.2

30.03

484.32

u/l

0.69

Acute renal failure

113

5.43

31.37

1.4

1.2

104.94

282.43

u/l

0.31

Other arrhythmias

120

4.78

30.79

1.2

63.42

327.13

u/l

0.62

Cardiomyopathy

8.84

29.77

1.2

56.78

790.92

u/l

0.65

Malignant neoplasm

103

158

3.86

29.38

1.2

1.3

105.57

260.65

u/l

0.33

105

Erysipelas

204

3.71

29.30

1.4

1.2

739.65

90.64

u/l

0.73

148

Condition for Implicit Sepsis (Organ dysfunction codes)

113

227

3.44

28.99

1.2

1.3

85.28

348.80

u/l

0.73

170

Malignant neoplasm, wide definition for exclusion

103

158

3.83

28.95

1.3

105.82

260.65

u/l

0.33

105

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

8.69

27.68

1.3

1.2

799.86

178.74

u/l

0.36

Pacemaker

196

3.93

27.42

1.4

1.2

40.87

394.85

u/l

0.86

140

Any gastric operation

4.84

27.19

1.4

1.2

455.85

29.42

u/l

0.60

GASTRO-related operations

4.84

27.19

1.4

1.2

455.85

29.42

u/l

0.60

Solid cancers, helper endpoint

157

3.73

26.98

1.2

1.3

113.21

263.03

u/l

0.31

104

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

118

242

3.18

26.43

1.3

1.2

38.28

236.51

u/l

0.93

176

Hypertension, essential

114

4.18

25.99

1.2

109.10

350.12

u/l

0.48

Implicit viral Sepsis

6.02

25.86

1.4

1.2

78.22

413.17

u/l

0.43

Viral Sepsis

6.02

25.86

1.4

1.2

78.22

413.17

u/l

0.43

Hypertensive diseases

115

4.13

25.61

1.2

108.13

346.75

u/l

0.48

Hypertension

115

4.13

25.60

1.2

108.13

346.75

u/l

0.48

Haemorrhage from respiratory passages

116

4.60

24.37

1.3

1.2

48.95

133.27

u/l

0.91

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

7.09

24.13

1.2

1.3

40.41

682.06

u/l

0.48

Infections, IBD-co-morbidities

9.85

24.12

1.4

1.0

1085.46

44.53

u/l

0.48

Hypertensive diseases (excluding secondary)

7.58

23.51

1.2

157.75

173.41

u/l

0.04

AV-block

6.82

23.31

1.2

1.1

21.68

606.44

u/l

0.60

All influenza

6.07

23.22

1.4

1.1

176.25

469.34

u/l

0.30

Implicit viral Sepsis

122

4.52

23.01

1.4

1.3

71.82

547.72

u/l

0.72

Aplastic and other anaemias

244

3.25

22.00

1.3

48.58

335.60

u/l

0.91

181

Asthma-related pneumonia

188

3.67

21.87

1.3

92.76

250.85

u/l

0.43

130

Asthma, hospital admissions 3, pneumonia

188

3.67

21.87

1.3

92.76

250.85

u/l

0.43

130

Asthma-related pneumonia or sepsis

188

3.67

21.87

1.3

92.76

250.85

u/l

0.43

130

Oral corticosteroids

128

279

2.72

21.55

1.3

1.2

310.90

90.43

u/l

0.43

196

Acute tubulo-interstitial nephritis

231

3.22

21.44

1.3

48.29

340.84

u/l

0.89

175

Cardiovascular diseases (excluding rheumatic etc)

6.51

20.85

1.3

820.75

149.60

u/l

0.48

Metabolic disorders

117

256

2.79

20.78

1.3

363.06

75.23

u/l

0.55

190

Any event in cancer register

186

3.11

20.59

1.2

1.3

113.39

218.90

u/l

0.26

129

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

5.08

19.63

1.3

1.2

830.84

444.09

u/l

0.18

Fever of other and unknown origin

208

3.26

19.53

1.2

1.3

509.04

234.16

u/l

0.23

152

Bleeding

112

298

2.68

19.28

1.3

448.97

177.76

u/l

0.34

218

First line medication for Crohn's disease

117

234

2.70

18.93

1.3

1.2

301.21

101.33

u/l

0.34

164

Cerebrovascular diseases (FINNGEN)

7.87

18.74

1.5

1.2

300.79

214.18

u/l

0.15

Diseases of arteries, arterioles and capillaries

103

278

2.74

18.74

1.3

455.53

185.46

u/l

0.30

202

Iron deficiency anaemia secondary to blood loss (chronic)

5.09

18.31

1.5

1.3

144.83

462.77

u/l

0.37

Early onset COPD, excluding more controls

16.15

18.26

1.2

36.78

2524.33

u/l

—

Transplanted organ and tissue status

7.47

18.22

1.5

1.2

1513.59

963.19

u/l

0.12

Percutaneous Coronary Intervention

214

2.84

18.21

1.3

39.93

390.40

u/l

1.02

160

ILD medications: immunosuppressive drugs

224

3.11

18.15

1.3

1.2

527.80

102.24

u/l

0.40

159

Enterocolitis due to Clostridium difficile

6.11

18.09

1.3

1.2

29.36

681.81

u/l

0.56

Complications of surgical and medical care, not elsewhere classified

119

324

2.52

18.03

1.4

1.2

618.38

89.71

u/l

0.73

234

Other bacterial intestinal infections

4.78

17.95

1.3

1.2

876.23

414.64

u/l

0.21

Inflammatory bowel disease treatment related agents

125

280

2.50

17.63

1.3

1.2

571.15

90.43

u/l

0.72

196

Other and unspecified anaemias

235

3.05

17.61

1.4

1.3

51.36

347.99

u/l

0.90

174

Cardiomyopathies, Primary/intrinsic

7.38

17.37

1.2

81.69

880.17

u/l

0.53

Other anaemias

237

3.01

17.27

1.4

1.3

51.36

344.26

u/l

0.90

176

Certain infectious and parasitic diseases

157

2.97

17.26

1.3

1.2

458.56

73.15

u/l

0.62

121

Complications of medical and surgical care

329

2.66

17.25

1.5

1.2

800.55

76.22

u/l

0.78

242

Cardiomyopathy (excluding other)

6.87

16.96

1.2

81.69

800.35

u/l

0.53

ILD medications: prednisolone, methylprednisolone, prednisone

117

259

2.53

16.91

1.3

1.2

634.85

92.41

u/l

0.70

188

Peripheral artery disease

226

2.89

16.84

1.3

66.85

206.18

u/l

0.51

164

Coronary revascularization (ANGIO or CABG)

214

2.75

16.72

1.3

39.87

390.40

u/l

1.02

160

Pain in throat and chest

161

3.02

16.52

1.3

1.2

461.57

114.76

u/l

0.42

120

Major coronary heart disease event

100

228

2.65

16.21

1.3

39.62

371.14

u/l

1.02

169

ILD medications

118

259

2.47

16.17

1.3

1.2

616.81

92.41

u/l

0.69

188

Symptoms and signs involving the circulatory and respiratory systems

161

2.86

16.13

1.2

400.58

114.76

u/l

0.41

120

Emergency coronary revascularization (for ACS)

104

246

2.57

15.98

1.3

39.81

345.18

u/l

1.01

183

Other chronic obstructive pulmonary disease

216

2.91

15.89

1.2

1.3

50.02

392.64

u/l

0.92

153

Hypertensive heart and/or renal disease

4.58

15.88

1.2

919.31

556.35

u/l

0.15

Hard cardiovascular diseases

201

2.73

15.74

1.3

107.69

215.61

u/l

0.31

151

Other disorders of fluid, electrolyte and acid-base balance

144

3.51

15.66

1.3

1.2

221.81

98.96

u/l

0.59

101

Bacterial intestinal infections, IBD co-morbidities

4.35

15.64

1.3

1.2

876.23

397.40

u/l

0.22

Intestinal infectious diseases

106

329

2.45

15.61

1.3

420.17

177.94

u/l

0.29

241

COPD, hospital admissions 3, with asthma pneumonia sepsis

152

3.33

15.56

1.2

1.3

49.72

498.98

u/l

0.81

106

Care involving dialysis

11.76

15.52

1.8

1.1

44.58

1537.32

u/l

0.54

Iron deficiency anaemia

215

3.03

15.52

1.3

100.34

380.84

u/l

0.66

155

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

302

2.68

15.46

1.5

1.2

911.52

72.47

u/l

0.80

219

Polyarthropathies

205

2.74

15.25

1.2

839.27

117.39

u/l

0.68

150

Other diseases of the respiratory system

118

3.83

15.23

1.3

190.77

336.10

u/l

0.21

Other respiratory disorders and diseases

118

3.83

15.23

1.3

190.77

336.10

u/l

0.21

COPD

224

2.82

15.21

1.2

1.3

50.10

383.12

u/l

0.92

157

Atherosclerosis, excluding cerebral and coronary sclerosis

218

2.80

14.96

1.3

55.74

211.85

u/l

0.57

159

Venous thromboembolism

289

2.68

14.96

1.4

1.3

553.40

168.31

u/l

0.40

204

Complications of procedures, not elsewhere classified

320

2.48

14.93

1.4

1.2

733.13

90.41

u/l

0.73

231

Glomerular disorders in diseases classified elsewhere

5.11

14.56

1.4

1.2

61.84

563.20

u/l

0.46

COPD, hospital admission 2, with asthma infections

173

3.08

14.50

1.2

1.3

51.20

434.40

u/l

0.80

123

DVT of lower extremities and pulmonary embolism

232

2.88

14.48

1.3

1.2

650.92

192.79

u/l

0.40

163

Nutritional anaemias

261

2.74

14.44

1.3

90.48

325.77

u/l

0.68

190

Major coronary heart disease event excluding revascularizations

201

2.72

14.44

1.4

1.3

42.21

416.11

u/l

1.00

148

Other bacterial intestinal infections

101

3.97

14.28

1.3

1.2

876.23

363.97

u/l

0.24

COPD, hospital admissions

242

2.69

14.16

1.2

1.3

49.69

343.75

u/l

0.88

172

Ischemic heart diseases

216

2.56

14.02

1.3

41.72

390.40

u/l

1.01

160

Glomerular diseases

4.06

13.96

1.4

1.2

1163.48

397.34

u/l

0.29

COPD, early/later onset

244

2.66

13.86

1.2

1.3

49.69

341.88

u/l

0.88

173

Any reimbursement code in KELA

5.91

13.82

1.4

1.2

900.04

23.12

u/l

0.49

Insulin medication

249

2.64

13.78

1.4

1.3

112.80

227.13

u/l

0.34

181

COPD-related respiratory insufficiency

4.59

13.74

1.1

1.3

27.14

559.72

u/l

0.58

Factors influencing health status and contact with health services

5.95

13.50

1.3

854.89

184.78

u/l

0.37

Disorders of lipoprotein metabolism and other lipidaemias

247

2.43

13.48

1.3

362.16

75.42

u/l

0.44

182

Covid-19 confirmed case

189

3.02

13.44

1.2

1.3

29.66

436.33

u/l

0.98

134

Other chronic obstructive pulmonary disease, including avohilmo

272

2.53

13.39

1.2

1.3

53.33

323.59

u/l

0.91

192

Neoplasms

100

3.23

13.31

1.3

1.2

99.06

432.43

u/l

0.49

General examination and investigation of persons without complaint and reported diagnosis

118

3.01

13.21

1.3

1.2

559.60

76.51

u/l

0.44

Asthma, hospital admission 2, infections

268

2.63

13.13

1.3

1.2

89.58

339.29

u/l

0.74

186

Asthma-related infections

268

2.63

13.13

1.3

1.2

89.58

339.29

u/l

0.74

186

Malignant neoplasm of digestive organs

122

3.31

13.11

1.3

57.06

308.10

u/l

0.45

Coronary atherosclerosis

196

2.62

13.11

1.3

41.26

426.73

u/l

1.00

144

Type 2 diabetes, wide definition

233

2.47

13.08

1.3

39.27

68.54

u/l

0.57

173

Other special examinations and investigations of persons without complaint or reported diagnosis

118

2.96

12.94

1.3

1.2

510.30

76.51

u/l

0.53

Disorders of gallbladder, biliary tract and pancreas

111

315

2.22

12.72

1.2

1.3

716.40

61.75

u/l

0.96

225

Non-Hodgkin lymphoma, all, including Hilmo

5.12

12.66

1.2

31.50

705.25

u/l

0.49

Diarrhoea and gastroenteritis of presumed infectious origin

270

2.54

12.66

1.3

566.96

200.07

u/l

0.32

199

COPD related to multimorbidity

214

2.69

12.50

1.2

1.3

50.17

355.67

u/l

0.79

153

Peripheral arterial reconstruction

116

3.55

12.50

1.4

1.2

30.76

331.46

u/l

0.58

Extracorporeal dialysis

9.01

12.23

1.8

1.1

47.18

1046.29

u/l

0.46

Myocardial infarction

176

2.72

12.22

1.2

1.3

44.53

476.59

u/l

1.00

128

Codeine

198

2.44

12.06

1.2

1.3

412.00

61.84

u/l

0.48

146

STROKE

134

2.95

11.90

1.4

1.3

184.45

75.44

u/l

0.47

108

Ischaemic heart disease, wide definition

241

2.32

11.32

1.3

40.18

361.24

u/l

1.01

174

Type 2 diabetes

253

2.24

11.17

1.2

1.3

407.72

85.23

u/l

0.49

189

Amputation

4.74

11.16

1.4

1.1

38.33

656.55

u/l

0.49

Hypo-osmolality and hyponatraemia

3.96

11.08

1.5

1.2

224.53

78.12

u/l

0.44

Chronic lower respiratory diseases

116

295

2.09

11.07

1.2

1.3

69.24

311.65

u/l

0.85

208

Primary_lymphoid and hematopoietic malignant neoplasms

141

3.13

11.07

1.3

28.90

282.06

u/l

0.58

Provisional assignment of new diseases of uncertain etiology

251

2.55

11.05

1.3

1.2

29.93

339.04

u/l

1.01

180

Diabetes, varying definitions

256

2.22

10.98

1.3

402.28

84.20

u/l

0.49

192

General symptoms and signs

221

2.25

10.96

1.2

1.3

79.38

221.71

u/l

0.50

162

Codes for special purposes

252

2.54

10.96

1.3

1.2

29.93

337.28

u/l

1.01

181

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.82

10.94

1.4

1.2

1403.26

662.77

u/l

0.21

GI-bleeding

196

2.76

10.90

1.4

1.2

940.45

223.31

u/l

0.44

146

Insulin, intermediate and long-acting

286

2.41

10.88

1.4

1.3

120.09

300.95

u/l

0.53

208

Other diseases of pancreas

5.41

10.87

1.2

3226.06

29.60

u/l

0.89

Other diseases of pericardium

17.92

10.72

1.5

1.2

40.27

2726.33

u/l

—

Diseases of oesophagus, stomach and duodenum

106

300

2.11

10.70

1.3

707.33

82.77

u/l

0.78

221

Codeine or tramadol medication

114

301

2.07

10.70

1.3

648.41

92.00

u/l

0.72

221

Cardiovascular diseases

4.74

10.65

1.2

1.3

933.96

135.58

u/l

0.41

Insulin, combination of fast acting with intermediate-acting or long-acting

310

2.30

10.62

1.4

1.3

112.80

284.85

u/l

0.56

228

Other disorders of skin and subcutaneous tissue

324

2.25

10.55

1.4

1.2

43.00

277.68

u/l

1.00

236

Diabetes mellitus

256

2.19

10.54

1.3

402.28

84.20

u/l

0.49

192

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

5.42

10.54

1.3

1.1

1156.32

216.21

u/l

0.37

Unspecified acute lower respiratory infection

3.93

10.28

1.1

1.3

100.06

514.39

u/l

0.50

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

254

2.18

10.10

1.3

445.97

84.37

u/l

0.51

190

Parasetamol

122

2.66

10.07

1.2

1.3

604.86

62.57

u/l

0.65

Insulin, fast-acting

182

2.75

10.06

1.3

1.2

127.53

261.00

u/l

0.32

130

Angina pectoris

188

2.45

10.03

1.3

47.26

443.96

u/l

0.98

138

Hypertensive Heart Disease

3.86

10.00

1.2

1143.04

511.33

u/l

0.22

Valvular operations

5.14

9.82

1.3

1.2

29.29

757.79

u/l

0.58

Other diseases of the digestive system

196

2.66

9.81

1.4

1.2

970.45

223.31

u/l

0.42

146

Osteopathies and chondropathies

253

2.40

9.76

1.4

1.3

62.69

202.93

u/l

0.59

183

Diabetes medication

281

2.09

9.73

1.3

409.34

204.49

u/l

0.26

205

Abnormal findings on examination of blood, without diagnosis

256

2.37

9.65

1.3

26.39

327.64

u/l

1.07

192

Nausea and vomiting

104

3.30

9.61

1.2

69.19

102.89

u/l

0.22

Diabetes, insulin treatment (Kela reimbursement)

100

293

2.06

9.56

1.3

1.2

415.99

77.45

u/l

0.52

217

Diseases of the digestive system

257

2.40

9.51

1.4

1.2

819.18

190.79

u/l

0.44

185

Presence of other devices

117

3.16

9.49

1.4

1.2

875.50

341.34

u/l

0.26

Abnormalities of heart beat

105

3.27

9.48

1.3

1.2

74.24

132.71

u/l

0.38

Autoimmune diseases excluding thyroid diseases, strict definition

100

265

2.07

9.39

1.2

1.3

391.27

209.14

u/l

0.21

197

Malignant neoplasm of urinary organs

5.15

9.35

1.2

2014.92

1005.05

u/l

0.19

Pulmonary embolism

167

2.76

9.34

1.4

1.2

157.26

231.71

u/l

0.15

122

Peripheral artery operations in Hilmo

3.74

9.30

1.4

1.2

38.18

500.62

u/l

0.56

Pulmonary heart disease

168

2.74

9.24

1.4

1.2

157.26

231.71

u/l

0.15

122

Pulmonary heart disease, diseases of pulmonary circulation

185

2.65

9.23

1.3

1.2

150.35

213.14

u/l

0.13

134

Autoimmune diseases excluding thyroid diseases

103

278

2.02

9.14

1.2

1.3

396.66

201.79

u/l

0.23

206

Endocrine, nutritional and metabolic diseases

135

2.48

9.11

1.3

574.35

67.03

u/l

0.62

104

Pure hypercholesterolaemia

243

2.18

9.06

1.3

875.70

76.38

u/l

0.76

179

Insulin, fast-acting or short human

194

2.58

8.93

1.3

1.2

127.53

243.94

u/l

0.29

140

Other acute lower respiratory infections

248

2.35

8.83

1.4

1.3

79.26

357.81

u/l

0.83

177

L04AD Calcineurin inhibitors

4.89

8.82

1.6

1.4

24.30

808.33

u/l

—

Acute pancreatitis

3.34

8.73

1.3

1.2

1264.17

77.35

u/l

0.66

Non-allergic asthma (mode)

10.58

8.71

1.2

1.1

36.20

2740.38

u/l

—

Asthma (diagnoses ohter than nonallergic)

351

2.03

8.55

1.3

83.62

267.01

u/l

0.71

247

Intestinal infectious diseases

111

333

1.90

8.47

1.3

429.74

165.13

u/l

0.35

244

Amputation of toe

4.47

8.36

1.4

1.2

40.54

680.85

u/l

0.47

Persons encountering health services for examination and investigation

118

2.51

8.36

1.3

1.2

555.18

76.51

u/l

0.50

Symptoms and signs involving the digestive system and abdomen

235

2.03

8.32

1.3

462.14

76.15

u/l

0.58

172

Fall on same level

102

286

1.95

8.22

1.3

1.2

443.79

187.51

u/l

0.30

211

Type 2 diabetes, definitions combined

250

2.04

8.14

1.2

1.3

433.08

85.58

u/l

0.50

186

Unspecified kidney failure

4.36

8.14

1.1

30.55

760.93

u/l

0.50

Malaise and fatigue

190

2.37

8.07

1.2

1.3

90.62

242.13

u/l

0.46

140

Type 2 diabetes, definitions combined, including avohilmo

249

2.04

8.04

1.2

1.3

426.86

86.34

u/l

0.49

183

Asthma/COPD (KELA code 203)

294

2.01

7.96

1.3

90.57

313.09

u/l

0.73

207

Other (not insulin) diabetes medications

276

1.98

7.92

1.2

1.3

434.17

208.49

u/l

0.27

200

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

318

1.93

7.90

1.4

1.2

815.59

90.58

u/l

0.73

235

Type 2 diabetes, strict (exclude DM1)

254

2.01

7.83

1.2

1.3

433.08

84.96

u/l

0.50

188

Myocardial infarction, strict

166

2.36

7.63

1.2

50.14

490.60

u/l

0.93

120

Dipeptidyl peptidase 4 (DPP-4) inhibitors

257

2.12

7.54

1.3

71.35

209.75

u/l

0.47

182

COPD, hospital admissions 1, only main diagnosis

194

2.34

7.54

1.2

1.3

53.85

399.13

u/l

0.78

135

Implicit fungal Sepsis

7.12

7.47

1.6

1.0

25.14

1164.95

u/l

—

Antihypertensive medication - note that there are other indications

3.33

7.43

1.3

30.40

694.58

u/l

0.62

Caries of dentine

3.08

7.40

1.5

1.3

25.41

92.33

u/l

0.72

Osteoporosis

121

2.79

7.40

1.6

1.3

81.04

327.15

u/l

0.47

Diabetic nephropathy, excluding more controls

3.38

7.37

1.3

1.2

62.75

588.20

u/l

0.51

104

288

1.87

7.35

1.3

423.39

182.40

u/l

0.27

214

L04AX Other immunosuppressants

252

2.22

7.30

1.2

1.3

621.13

222.79

u/l

0.29

181

Sequelae of external causes of morbidity and mortality

126

2.78

7.29

1.4

1.3

70.61

300.83

u/l

0.46

Disorders of lens

224

2.06

7.26

1.4

1.3

43.21

215.33

u/l

0.75

174

Infections of the skin and subcutaneous tissue

263

2.19

7.24

1.4

1.3

130.67

322.70

u/l

0.50

187

Biguanides

290

1.91

7.22

1.2

1.3

441.44

202.00

u/l

0.29

207

Acute pancreatitis (for exclusion)

105

2.96

7.21

1.3

1264.17

79.12

u/l

0.66

ILD, hospital admission 2, with pulmonary infections

5.78

7.20

1.3

1.0

383.58

909.00

u/l

0.25

Use of hypnotics and sedatives

306

1.86

7.10

1.3

94.81

286.70

u/l

0.65

224

Tramadol

194

2.12

7.05

1.3

1.2

137.39

62.63

u/l

0.61

142

Second line medication for Crohn's disease

256

2.19

7.04

1.2

1.3

621.13

219.58

u/l

0.29

184

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

302

2.09

7.01

1.5

1.2

596.68

194.38

u/l

0.34

215

Certain infectious and parasitic diseases

142

2.22

6.99

1.4

1.2

566.82

49.35

u/l

0.54

107

Gout

158

2.45

6.99

1.3

1.2

1008.27

115.95

u/l

0.43

111

Later onset COPD

161

2.38

6.98

1.2

1.3

57.94

491.82

u/l

0.79

108

Other and unspecified iron deficiency

164

2.50

6.96

1.3

1.2

29.43

249.44

u/l

0.61

116

Genitourinary diseases

109

2.39

6.78

1.3

1.2

690.36

69.31

u/l

0.56

Gout, FINNGEN

184

2.39

6.78

1.3

1008.27

90.95

u/l

0.45

130

ILD, hospital admissions 3, with pneumonia sepsis

5.65

6.75

1.3

1.0

383.58

1031.00

u/l

0.27

Oedema, not elsewhere classified

141

2.59

6.74

1.4

1.3

1094.79

316.97

u/l

0.32

101

Bronchitis

345

1.81

6.69

1.3

67.05

269.84

u/l

0.88

254

Senile cataract

216

2.02

6.56

1.4

1.3

32.89

216.99

u/l

0.78

167

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

5.81

6.47

1.3

1.0

418.09

35.06

u/l

0.60

Pain in limb

253

1.96

6.45

1.4

1.3

648.77

193.62

u/l

0.43

184

Dental caries

108

2.76

6.36

1.5

1.2

25.35

87.76

u/l

0.73

Seropositive rheumatoid arthritis

118

2.71

6.36

1.2

1.3

23.94

77.55

u/l

1.02

Explicit bacterial Sepsis

4.06

6.34

1.2

1.3

38.70

693.91

u/l

—

Opioids

199

1.96

6.17

1.2

1.3

570.03

61.84

u/l

0.66

146

Symptoms and signs involving the urinary system

323

1.86

6.15

1.4

1.3

509.32

174.32

u/l

0.33

230

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

121

2.65

6.13

1.2

1.3

23.94

313.08

u/l

0.60

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

4.12

6.08

1.4

1.2

18.00

953.92

u/l

—

Polyneuropathies and other disorders of the peripheral nervous system

123

2.61

5.95

1.2

1.3

169.95

314.97

u/l

0.22

Other/unspecified seropositive rheumatoid arthritis

123

2.61

5.95

1.2

1.3

23.94

307.07

u/l

0.60

Nerve, nerve root and plexus disorders

341

1.74

5.84

1.3

507.20

159.83

u/l

0.41

249

Calcific aortic valvular stenosis, operated

210

2.17

5.84

1.4

1.2

55.22

370.21

u/l

0.79

150

Calcific aortic valvular stenosis

210

2.17

5.84

1.4

1.2

55.22

370.21

u/l

0.79

150

Calcific aortic valvular stenosis, diagnosis (helper)

210

2.17

5.84

1.4

1.2

55.22

370.21

u/l

0.79

150

Operations 2 for CAVS

210

2.17

5.84

1.4

1.2

55.22

370.21

u/l

0.79

150

Calcific aortic valvular stenosis, including rheumatic fever

210

2.17

5.82

1.4

1.2

55.22

370.21

u/l

0.79

150

Hernia of abdominal wall, postoperative

3.78

5.80

1.6

1.1

261.00

29.11

u/l

0.47

Seropositive rheumatoid arthritis, wide

125

2.56

5.77

1.2

1.3

23.94

301.52

u/l

0.61

Syncope and collapse

185

2.18

5.74

1.3

80.57

248.39

u/l

0.50

136

Dilated cardiomyopathy

3.15

5.73

1.3

1.2

93.27

457.04

u/l

0.40

Streptococcal septicaemia

3.91

5.71

1.3

1.1

38.70

129.28

u/l

—

Disorders of choroid and retina

329

1.79

5.68

1.2

1.3

52.29

274.76

u/l

0.95

241

Acute peritonitis

5.58

5.68

1.3

1.1

52.30

19.95

u/l

—

Asthma, hospital admissions , main diagnosis only

338

1.85

5.62

1.4

1.3

46.21

290.54

u/l

1.05

235

Shoulder lesions

244

1.86

5.60

1.2

531.45

196.02

u/l

0.30

177

Supplementary factors related to causes of morbidity and mortality classified elsewhere

134

2.47

5.51

1.4

1.2

309.19

307.63

u/l

0.00

Gastroduodenal ulcer

146

2.39

5.48

1.2

1.3

27.74

89.30

u/l

0.91

108

Nonischemic cardiomyopathy

3.62

5.47

1.4

1.2

27.22

796.56

u/l

—

Cough

121

2.50

5.46

1.4

1.2

1305.95

128.30

u/l

0.44

Unstable angina pectoris

158

2.20

5.43

1.4

1.2

35.18

509.25

u/l

0.95

113

Reimbursement for rheumatic diseases

277

1.98

5.40

1.3

53.26

194.21

u/l

0.66

196

Diabetic nephropathy

105

2.64

5.34

1.3

60.88

699.73

u/l

0.80

Rheumatoid arthritis

143

2.32

5.33

1.2

771.33

102.73

u/l

0.42

106

Gastrointestinal diseases

2.34

5.30

1.3

787.53

52.32

u/l

0.54

Cutaneous abscess, furuncle and carbuncle

107

2.62

5.29

1.4

1.3

202.10

393.32

u/l

0.27

Fungal Sepsis

6.71

5.25

1.7

1.1

26.17

26.92

u/l

—

Misadventures to patients during surgical and medical care

3.13

5.18

1.7

1.3

1976.46

92.52

u/l

0.45

Hypokalaemia

3.48

5.16

1.1

1.2

239.27

104.39

u/l

0.52

DVT of lower extremities

2.69

5.15

1.3

1.2

1822.73

70.62

u/l

0.50

Finngen Rheumatological endpoints

240

1.80

5.08

1.2

1.3

435.68

111.07

u/l

0.37

176

Malignant neoplasm of pancreas

5.67

5.06

1.0

1.3

23.63

1987.55

u/l

—

Other soft tissue disorders, not elsewhere classified

257

1.78

5.04

1.3

663.30

191.10

u/l

0.44

187

Other infectious diseases

3.57

5.04

1.6

1.2

126.20

781.16

u/l

—

All influenza (not pneumonia)

4.45

5.04

1.1

145.80

737.49

u/l

—

Myocardial infarction, without ST-elevation

259

1.94

5.04

1.3

31.44

335.12

u/l

1.03

186

Abnormal findings on diagnostic imaging of other body structures

3.17

5.03

2.0

1.3

46.64

566.85

u/l

0.54

Type of accident

122

2.46

5.02

1.5

1.3

346.22

329.09

u/l

0.02

Abnormal serum enzyme levels

200

2.10

4.95

1.3

28.52

399.30

u/l

1.00

149

Abdominal and pelvic pain

235

1.75

4.88

1.4

1.3

494.13

76.15

u/l

0.59

172

Ulcer of lower limb, not elsewhere classified

2.78

4.86

1.5

1.3

43.00

429.78

u/l

0.54

Other diseases of intestines

286

1.71

4.85

1.2

1.3

93.67

299.57

u/l

0.67

219

Type 1 diabetes, wide definition, subgroup 1

2.99

4.81

1.3

1.2

20.56

108.02

u/l

—

Other retinal disorders

296

1.79

4.78

1.2

1.3

38.63

294.03

u/l

1.00

217

Other disorders of skin and subcutaneous tissue, not elsewhere classified

2.88

4.75

1.1

1.3

41.19

474.45

u/l

0.54

Sequelae with surgical and medical care as external cause

102

2.55

4.70

1.4

1.3

94.27

363.56

u/l

0.42

Early onset COPD

120

2.42

4.70

1.2

1.3

36.78

345.90

u/l

0.68

Falls/tendency to fall

245

1.72

4.68

1.3

456.12

94.07

u/l

0.48

180

Pain (limb, back, neck, head abdominally)

169

1.87

4.60

1.3

1.2

649.34

58.98

u/l

0.64

122

Injury, poisoning and certain other consequences of external causes

110

2.10

4.58

1.3

1.2

700.11

114.02

u/l

0.47

Neurological diseases

192

1.81

4.55

1.3

510.50

92.52

u/l

0.47

136

Rheumatoid arthritis, including avohilmo

186

2.10

4.55

1.2

1.3

747.62

66.25

u/l

0.45

131

178

2.12

4.54

1.3

1.2

45.97

263.70

u/l

0.66

126

Other gastritis (incl. Duodenitis)

104

2.50

4.53

1.2

32.22

66.18

u/l

0.50

Vascular disorders of the intestines

4.18

4.51

1.3

1.2

66.67

972.00

u/l

—

Used for control exclusion in common control thyroid runs

258

1.68

4.50

1.3

447.03

213.71

u/l

0.26

192

Cerebrovascular diseases

318

1.70

4.49

1.3

757.98

152.79

u/l

0.48

236

External causes of morbidity and mortality

132

1.97

4.45

1.3

1.2

649.75

99.64

u/l

0.48

104

Injuries to the knee and lower leg

339

1.60

4.37

1.3

447.37

169.44

u/l

0.34

245

Cholelithiasis, broad definition with cholecystitis

303

1.69

4.29

1.2

1.3

449.60

61.97

u/l

0.48

218

Conductive and sensorineural hearing loss

309

1.68

4.29

1.2

1.3

34.86

286.40

u/l

1.05

228

L04AA Selective immunosuppressants

2.53

4.28

1.5

1.3

29.71

433.53

u/l

0.67

Acute bronchitis

194

2.02

4.24

1.5

1.3

85.53

254.15

u/l

0.50

134

Other respiratory diseases principally affecting the interstitium

114

2.37

4.22

1.3

1.2

312.60

344.59

u/l

0.03

Malignant neoplasm of pancreas, including Hilmo

4.13

4.20

1.1

1.3

24.22

1161.90

u/l

—

Type 1 diabetes

2.55

4.19

1.3

1.2

66.73

152.59

u/l

0.54

Fracture of lower leg, including ankle

259

1.87

4.19

1.4

1.3

116.58

201.48

u/l

0.27

188

Diseases of liver

173

2.08

4.15

1.6

1.2

206.04

239.08

u/l

0.05

125

Intracranial trauma

143

2.02

4.06

1.3

1.2

183.79

68.23

u/l

0.47

105

Diarrhoea and gastroenteritis of presumed infectious origin

328

1.63

4.00

1.3

557.89

168.18

u/l

0.39

238

Spinal stenosis

232

1.80

3.99

1.1

1.3

709.87

222.51

u/l

0.33

165

Adjustment and management of implanted device

2.67

3.98

1.1

1.2

24.60

502.69

u/l

0.57

Sensorineural hearing loss

303

1.66

3.95

1.2

1.3

35.00

292.13

u/l

1.05

223

Hernia

325

1.63

3.94

1.3

142.69

271.76

u/l

0.38

233

Presbycusis

2.57

3.89

1.6

1.2

95.77

501.50

u/l

0.47

Type 1 diabetes, wide definition

2.63

3.88

1.3

1.2

20.56

148.18

u/l

—

Other arthritis (FG)

132

2.20

3.84

1.1

1.3

38.48

119.29

u/l

1.16

104

Diseases of peritoneum

2.97

3.84

1.3

1.2

2014.82

90.38

u/l

0.46

Diseases of the musculoskeletal system and connective tissue

2.05

3.82

1.1

1.2

724.68

90.03

u/l

0.43

Obesity related asthma

159

2.08

3.80

1.4

1.3

27.93

271.39

u/l

0.74

121

Other skin changes

101

2.38

3.80

1.4

1.2

32.75

373.38

u/l

0.57

Gastric ulcer

2.42

3.79

1.0

1.2

25.71

72.05

u/l

0.62

Fracture of lumbar spine and pelvis

120

2.25

3.77

1.4

1.3

79.06

336.88

u/l

0.47

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

133

1.99

3.73

1.3

165.60

292.04

u/l

0.19

174

1.95

3.73

1.1

1.3

33.04

451.13

u/l

0.87

120

Colorectal cancer

2.45

3.69

1.5

1.2

32.87

428.57

u/l

0.48

Glomerulonephritis

3.01

3.68

1.3

3663.71

661.63

u/l

—

Infective dermatitis

2.79

3.68

1.2

1.3

94.50

535.63

u/l

0.47

Other specified/unspecified arthritis

122

2.22

3.66

1.1

1.3

40.39

120.50

u/l

1.01

Intestinal stricture

178

1.97

3.51

1.3

27.04

246.25

u/l

0.71

130

Benign neoplasm of colon, rectum, anus and anal canal

338

1.64

3.50

1.5

1.2

595.12

162.09

u/l

0.39

237

Coronary artery bypass grafting

115

2.08

3.50

1.3

1.2

70.19

656.88

u/l

0.80

Injuries to the head

351

1.54

3.47

1.3

475.26

177.28

u/l

0.34

258

Other embolism and thrombosis

2.61

3.46

1.4

1.3

26.30

83.45

u/l

—

Other functional intestinal disorders

218

1.83

3.45

1.2

1.3

57.55

356.77

u/l

0.85

166

Unspecified haematuria

224

1.78

3.44

1.3

1.2

877.31

217.75

u/l

0.38

162

Alcohol use disorder, Swedish definition

277

1.72

3.40

1.2

1.3

719.39

198.28

u/l

0.42

199

Other and unspecified polyneuropathies, also in other diseases

113

2.22

3.40

1.2

1.3

185.12

346.50

u/l

0.22

Other CVD

120

2.17

3.37

1.1

1.3

28.50

329.50

u/l

0.59

Gonarthrosis [arthrosis of knee](FG)

229

1.65

3.36

1.3

553.06

98.26

u/l

0.42

168

Colorectal adenocarcinoma

2.50

3.35

1.2

34.31

469.94

u/l

0.48

Autoimmune diseases

279

1.55

3.32

1.3

469.15

200.90

u/l

0.29

207

Diabetic retinopathy, excluding more controls

2.17

3.32

1.3

1.2

23.33

543.20

u/l

0.58

Stroke, including SAH

291

1.62

3.28

1.3

875.86

162.24

u/l

0.49

218

Gout, idiopatic and unspecified

169

1.96

3.27

1.3

1299.25

258.92

u/l

0.37

122

Sequelae of injuries, of poisoning and of other consequences of external causes

103

2.24

3.21

1.3

103.48

393.55

u/l

0.50

Functional dyspepsia

103

2.24

3.21

1.1

1.2

3020.19

70.02

u/l

0.79

Diabetic maculopathy, excluding more controls

2.86

3.18

1.5

1.1

23.25

38.11

u/l

—

Soft tissue disorders

258

1.56

3.14

1.2

1.3

148.52

191.10

u/l

0.12

187

Mycoses

124

2.10

3.13

1.5

1.2

28.25

337.99

u/l

0.69

Other disorders of kidney and ureter

2.47

3.12

1.0

1.3

3203.75

492.02

u/l

—

Gastro-oesophageal reflux disease

287

1.65

3.11

1.4

1.3

110.47

81.61

u/l

0.15

211

Asthma, including avohilmo

347

1.49

3.09

1.3

449.62

170.90

u/l

0.33

244

Corns and callosities

3.68

3.08

1.3

1.2

26.17

1174.19

u/l

—

Constipation

343

1.53

3.05

1.2

1.3

79.40

257.79

u/l

0.73

255

Injuries to the abdomen, lower back, lumbar spine and pelvis

207

1.82

3.05

1.3

1059.31

233.13

u/l

0.39

146

Malignant neoplasm of colon, including Hilmo

2.43

3.03

1.5

1.2

32.77

488.48

u/l

0.49

Malignant neoplasm of breast, HER2-negative, including Hilmo

2.22

3.03

1.3

1.2

34.79

568.40

u/l

0.52

Malignant neoplasm of breast, including Hilmo

2.22

3.03

1.3

1.2

34.79

568.40

u/l

0.52

Deviated nasal septum

167

1.92

3.02

1.4

1.3

75.43

484.11

u/l

0.81

118

Cellulitis

106

2.17

3.02

1.2

1.3

67.89

393.51

u/l

0.61

Dermatitis

314

1.65

3.00

1.3

1.2

56.38

284.29

u/l

0.87

223

Viral and other specified intestinal infections

2.89

2.99

1.5

1.2

144.99

682.16

u/l

—

Phlebitis and thrombophlebitis (not including DVT)

100

2.20

2.98

1.5

1.2

1527.53

113.33

u/l

0.47

Other external causes of accidental injury

191

1.63

2.97

1.3

556.09

90.47

u/l

0.48

141

Accidents

191

1.63

2.97

1.3

556.11

90.47

u/l

0.48

141

132

2.00

2.94

1.1

1.2

35.59

323.59

u/l

0.58

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

2.28

2.93

1.6

1.3

37.62

380.15

u/l

0.55

Gout, strict definition

128

2.03

2.90

1.3

30.13

292.19

u/l

0.58

Malignant neoplasm of breast, HER2-negative

2.21

2.90

1.3

1.2

35.06

586.56

u/l

0.50

Disorders of thyroid, IBD co-morbidities

3.37

2.90

1.1

1.0

22.86

38.85

u/l

—

Chronic gastritis

142

1.97

2.88

1.4

1.2

26.26

69.24

u/l

0.92

Impingement syndrome of shoulder

122

2.05

2.86

1.2

1.3

1483.17

314.51

u/l

0.37

Other cataract

182

1.75

2.86

1.2

1.3

44.83

237.00

u/l

0.68

146

Dorsalgia

260

1.52

2.78

1.3

504.56

203.96

u/l

0.26

186

Rotator cuff syndrome

239

1.62

2.78

1.2

63.78

199.20

u/l

0.53

173

Paralytic ileus and intestinal obstruction

137

1.97

2.78

1.3

1.2

25.74

518.55

u/l

0.88

102

Hypotension

110

2.09

2.77

1.1

1.3

29.31

352.92

u/l

0.58

Cholelithiasis

300

1.54

2.77

1.2

1.3

54.18

57.88

u/l

0.05

215

284

1.62

2.75

1.2

1.3

738.03

193.36

u/l

0.43

205

Malignant neoplasm of breast

2.14

2.71

1.3

1.2

35.06

568.40

u/l

0.51

Symptoms and signs involving cognition, perception, emotional state and behaviour

348

1.49

2.70

1.2

1.3

542.59

174.56

u/l

0.33

258

Basal cell carcinoma

123

1.86

2.69

1.3

150.05

301.81

u/l

0.22

Other symptoms and signs involving the nervous and musculoskeletal systems

204

1.77

2.67

1.2

1.3

66.53

226.20

u/l

0.54

151

Polycystic ovarian syndrome, consortium definition

126

1.79

2.67

1.2

1.3

973.50

87.45

u/l

0.47

Fracture of rib(s), sternum and thoracic spine

175

1.83

2.67

1.2

1.3

85.96

266.83

u/l

0.48

121

Diseases of male genital organs

148

1.67

2.64

1.3

1.2

215.08

274.14

u/l

0.09

111

Volume depletion

2.80

2.64

1.3

1.2

50.33

116.89

u/l

—

Interstitial lung disease endpoints

2.12

2.64

1.3

1.2

331.50

380.03

u/l

0.04

Other interstitial pulmonary diseases

2.12

2.64

1.3

1.2

331.50

380.03

u/l

0.04

Interstitial lung disease

2.12

2.64

1.3

1.2

331.50

380.03

u/l

0.04

Concussion

142

1.84

2.63

1.3

1.2

165.81

68.55

u/l

0.33

104

Other malignant neoplasms of skin (=non-melanoma skin cancer)

123

1.84

2.62

1.2

1.3

197.70

301.81

u/l

0.14

Diabetic retinopathy, strict definition

2.13

2.61

1.4

1.3

21.50

406.62

u/l

—

288

1.59

2.59

1.2

1.3

719.39

190.99

u/l

0.43

208

Injuries to the thorax

252

1.67

2.56

1.4

1.3

77.49

350.12

u/l

0.76

169

Ischaemic Stroke, excluding all haemorrhages

284

1.55

2.55

1.3

926.59

170.25

u/l

0.45

212

Noninfective enteritis and colitis

215

1.72

2.53

1.3

34.70

231.29

u/l

0.80

160

Other intervertebral disc disorders

257

1.52

2.53

1.3

720.12

206.69

u/l

0.39

183

Cardiodefibrillation

238

1.68

2.51

1.5

1.3

49.96

355.38

u/l

0.88

167

Other diseases of anus and rectum

150

1.86

2.49

1.5

1.2

199.10

497.80

u/l

0.41

110

Medical observation and evaluation for suspected diseases and conditions

118

1.73

2.48

1.2

834.47

76.51

u/l

0.52

Varicose veins

255

1.57

2.46

1.4

1.2

47.47

73.84

u/l

0.47

187

Other disorders of ear

320

1.47

2.45

1.2

1.3

32.89

277.73

u/l

1.07

236

Symptoms and signs involving the nervous and musculoskeletal systems

303

1.58

2.42

1.2

1.3

55.38

300.54

u/l

0.91

213

Status post-ami

114

1.87

2.42

1.4

1.2

66.25

691.29

u/l

0.89

Tuberculosis

2.90

2.41

1.1

32.17

768.41

u/l

—

Basal cell carcinoma, including avohilmo

123

1.79

2.38

1.3

151.10

301.81

u/l

0.21

Other nutritional deficiencies

257

1.61

2.37

1.3

80.55

329.97

u/l

0.76

187

ILD, hospital admissions

2.07

2.36

1.3

1.2

355.15

380.17

u/l

0.02

Stroke, excluding SAH

290

1.51

2.35

1.3

954.44

167.90

u/l

0.48

216

Malignant neoplasm of breast, HER-positive

2.19

2.35

1.3

1.2

33.38

633.02

u/l

0.51

Spondylopathies

250

1.51

2.35

1.1

1.3

613.23

211.33

u/l

0.30

178

Diseases of the eye and adnexa

176

1.57

2.34

1.4

1.3

616.84

88.32

u/l

0.54

139

Degeneration of macula and posterior pole

254

1.57

2.34

1.2

1.3

46.03

312.03

u/l

0.85

185

L01XE Protein kinase inhibitors

3.22

2.30

1.4

1.2

3246.00

1232.10

u/l

—

Umbilical hernia

133

1.88

2.30

1.4

1.3

43.66

572.86

u/l

0.88

Malignant neoplasm of breast, ER-positive, including Hilmo

2.17

2.29

1.3

1.2

33.38

633.02

u/l

0.51

Retention of urine

181

1.68

2.28

1.2

1.3

73.65

248.73

u/l

0.51

132

Renal cell carcinoma of kidney

4.63

2.27

1.2

4280.83

22.86

u/l

—

Hypercalcemia

3.90

2.25

1.1

21.29

1821.67

u/l

—

Sleep apnoea

334

1.43

2.22

1.4

1.3

910.95

79.84

u/l

0.80

235

Abnormal results of function studies

2.86

2.20

1.3

1.4

16.00

856.97

u/l

—

Malignant neoplasm of skin

136

1.71

2.19

1.2

1.3

196.40

283.34

u/l

0.12

Dorsopathies

261

1.44

2.18

1.2

1.3

93.80

203.96

u/l

0.40

186

Viral and other specified intestinal infections

2.13

2.17

1.4

1.2

170.89

479.15

u/l

—

Low back pain

256

1.51

2.16

1.3

748.28

206.70

u/l

0.34

183

Disorders of other endocrine glands

192

1.69

2.16

1.1

1.3

59.73

246.77

u/l

0.62

141

Other dorsopathies, not elsewhere classified

261

1.44

2.16

1.2

1.3

99.72

203.96

u/l

0.37

186

Unspecified fall

261

1.59

2.16

1.2

1.3

730.12

79.80

u/l

0.46

183

Hyperplasia of prostate

138

1.65

2.16

1.4

1.2

37.32

295.82

u/l

0.52

102

Cholecystectomy

331

1.49

2.15

1.1

1.3

58.95

272.53

u/l

0.88

240

Other diseases of blood and blood-forming organs, wide

115

1.91

2.15

1.3

303.00

322.57

u/l

0.02

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

137

1.83

2.12

1.2

1.3

38.19

300.24

u/l

0.66

104

Hyperlipidaemia, other/unspecified

202

1.64

2.10

1.1

1.3

1012.14

78.81

u/l

0.45

146

Other or unspecified ileus, impaction or obstruction

1.98

2.04

1.3

1.2

25.77

374.03

u/l

0.59

Gout, unspecified

140

1.79

2.00

1.2

1.3

33.47

300.51

u/l

0.67

103

Episodal and paroxysmal disorders

287

1.38

1.88

1.3

508.73

85.80

u/l

0.50

206

Benign neoplasm: Rectum, anus and anal canal

121

1.82

1.87

1.4

1.2

45.29

316.91

u/l

0.54

Sulfonylureas

186

1.58

1.87

1.2

58.80

256.76

u/l

0.51

133

Candidiasis

114

1.84

1.86

1.5

1.3

1828.17

65.35

u/l

0.46

Sub-endpoint used in defining T1D endpoints

134

1.76

1.85

1.3

1.2

62.83

363.51

u/l

0.69

Iridocyclitis

100

1.90

1.85

1.4

1.2

158.79

401.59

u/l

0.37

Anterior Iridocyclitis

1.94

1.84

1.4

1.3

169.92

378.38

u/l

0.28

Dental operations

184

1.48

1.83

1.3

664.34

62.86

u/l

0.52

129

Injuries to the ankle and foot

253

1.51

1.81

1.2

1.3

1773.75

91.83

u/l

0.79

187

Gonarthrosis

201

1.47

1.81

1.2

37.15

100.03

u/l

1.27

148

malignant neoplasm of male genital organs

1.82

1.80

1.3

1.4

32.47

43.71

u/l

0.31

Obesity due to excess calories

191

1.62

1.80

1.3

92.52

238.27

u/l

0.43

142

Benign neoplasm: Colon

328

1.46

1.78

1.6

1.2

768.92

161.65

u/l

0.43

233

Fracture of foot, except ankle

1.90

1.75

1.2

1.3

168.20

64.14

u/l

—

Missing teeth due to accident, extraction or parodontitis

333

1.44

1.74

1.5

1.3

692.97

185.60

u/l

0.40

234

ILD, hospital admissions 1, main diag only

1.93

1.74

1.3

1.2

22.10

415.99

u/l

—

Diseases of the skin and subcutaneous tissue

253

1.39

1.74

1.3

1.2

72.96

325.00

u/l

0.78

187

Behavioural syndromes associated with physiological disturbances and physical factors

337

0.63

1.74

1.3

31.30

279.98

u/l

1.13

243

Statin medication

155

1.52

1.71

1.3

42.87

312.90

u/l

0.82

119

Epilepsy

147

1.70

1.71

1.1

1.2

25.58

73.71

u/l

0.86

110

Complications of internal orthopaedic prosthetic devices, implants and grafts

125

1.76

1.71

1.4

1.2

1714.33

63.71

u/l

0.46

Disorders of parathyroid gland

109

1.81

1.70

1.1

1.3

73.15

343.37

u/l

0.49

Systemic connective tissue disorders

171

1.64

1.69

1.1

1.2

1587.93

59.78

u/l

0.47

123

Hyperparathyroidism

1.87

1.69

1.1

1.3

84.54

386.28

u/l

0.48

Acute and subacute iridocyclitis

1.95

1.69

1.3

1.2

197.09

412.11

u/l

0.26

Convulsions, not elsewhere classified

1.91

1.68

1.5

1.3

32.67

452.58

u/l

0.70

Wet age-related macular degeneration

115

1.77

1.66

1.1

1.2

25.93

368.03

u/l

0.61

Other disorders of urethra and urinary system

280

1.42

1.66

1.3

1.2

619.08

202.26

u/l

0.32

203

Procreative management

1.81

1.66

1.2

1.3

32.04

460.81

u/l

0.78

Examination and observation for other reasons

115

1.61

1.66

1.1

1.2

1091.50

77.11

u/l

0.46

Arthropathies

212

1.41

1.63

1.3

1.2

526.14

115.10

u/l

0.39

155

Diabetic retinopathy

150

1.54

1.62

1.2

1.3

25.42

516.59

u/l

0.96

109

Malignant neoplasm of prostate, including Hilmo

1.75

1.62

1.3

32.00

42.98

u/l

0.31

Benign neoplasm: Rectum

113

1.77

1.60

1.4

1.2

46.20

338.93

u/l

0.54

Amiodarone users

2.00

1.59

1.1

1.3

21.67

508.08

u/l

—

Cervical disc disorders

183

1.59

1.56

1.2

1340.75

273.01

u/l

0.38

127

Benign neoplasms

271

1.36

1.56

1.3

89.39

209.57

u/l

0.46

190

Mental and behavioural disorders due to alcohol, excluding acute intoxication

238

1.51

1.55

1.2

1.3

165.30

354.72

u/l

0.40

170

Redundant prepuce, phimosis and paraphimosis

1.85

1.55

1.1

1.2

215.60

419.30

u/l

—

Substance abuse, excluding more controls

252

1.45

1.54

1.2

1.3

143.31

328.67

u/l

0.44

182

Alcohol use disorder, ICD-based

224

1.52

1.53

1.2

1.3

175.84

366.78

u/l

0.38

161

Transport accidents

165

1.56

1.51

1.2

1.3

40.08

99.52

u/l

0.97

118

Diseases of oral cavity, salivary glands and jaws

193

1.41

1.50

1.3

728.29

87.93

u/l

0.51

127

Memory loss

2.16

1.50

1.2

1.3

173.02

652.56

u/l

—

Acute upper respiratory infections

354

1.32

1.50

1.2

1.3

557.85

172.44

u/l

0.32

261

Other noninfective gastroenteritis and colitis

108

1.76

1.49

1.1

1.3

31.64

330.47

u/l

0.57

Other neurological diseases

346

1.36

1.49

1.3

29.54

267.02

u/l

1.12

251

Carbimazole or st.post thyroidectomy, condition for graves disease

1.90

1.49

1.1

1.3

38.20

460.24

u/l

—

Presence of other functional implants

200

1.46

1.48

1.4

1.2

60.75

248.06

u/l

0.64

143

Intracranial injury

291

1.43

1.48

1.4

1.3

172.92

198.90

u/l

0.06

212

Leisure time condition

1.84

1.45

1.3

276.09

368.20

u/l

—

Sleep disorders

327

0.66

1.44

1.3

31.30

286.72

u/l

1.13

236

Malignant neoplasm of ovary, including Hilmo

3.13

1.44

2.2

1.3

214.80

3654.83

u/l

—

Viral infections characterized by skin and mucous membrane lesions

188

1.54

1.41

1.3

1.2

231.76

217.01

u/l

0.02

140

Obesity

253

1.45

1.39

1.4

1.3

82.03

332.22

u/l

0.76

186

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

255

1.45

1.38

1.5

1.3

78.43

361.00

u/l

0.87

181

Obesity and other hyperalimentation

253

1.45

1.38

1.4

1.3

82.03

332.22

u/l

0.76

186

Striking against or struck by other objects

134

1.64

1.38

1.2

1.3

30.19

356.78

u/l

0.83

Disorders of sclera, cornea, iris and ciliary body

263

1.45

1.38

1.4

1.3

1072.08

204.14

u/l

0.42

189

Diabetic maculopathy

1.95

1.37

1.5

1.3

23.25

530.61

u/l

—

Haemorrhoids and perianal venous thrombosis

166

1.56

1.35

1.2

1.3

30.86

449.98

u/l

0.93

125

Other diseases of upper respiratory tract

331

1.29

1.35

1.3

52.19

288.05

u/l

1.00

237

Dizziness and giddiness

329

1.35

1.34

1.2

1.3

698.13

171.77

u/l

0.36

242

Seropositive rheumatoid arthritis, strict definition

1.87

1.34

1.4

1.3

27.38

477.52

u/l

—

Other antidepressants

308

1.30

1.33

1.4

1.2

94.17

302.83

u/l

0.70

215

Sarcoidosis

1.97

1.32

1.6

1.3

284.00

525.07

u/l

0.18

Artificial opening status

2.78

1.28

1.6

1.1

26.60

1825.50

u/l

—

Autoimmune diseases related-to ILD

366

1.33

1.28

1.3

55.11

247.06

u/l

0.88

268

Combinations of oral blood glucose lowering drugs

161

1.55

1.28

1.3

1434.19

298.59

u/l

0.38

115

Candidiasis

1.94

1.27

1.7

1.4

33.14

544.02

u/l

—

Unspecified urinary incontinence

2.29

1.26

1.3

37.63

997.44

u/l

—

Lumbar disc prolapse

243

1.39

1.26

1.4

1.3

962.06

217.82

u/l

0.44

172

Malignant neoplasm of prostate

1.65

1.26

1.3

1.4

33.13

43.71

u/l

0.28

Symptoms and signs involving the skin and subcutaneous tissue

354

1.35

1.25

1.3

56.65

260.03

u/l

0.87

251

Myocardial infarction, unclassifiable

144

1.55

1.25

1.2

28.31

274.97

u/l

0.59

100

Cystitis

289

0.70

1.25

1.2

1.3

46.84

197.18

u/l

0.64

209

Substance abuse

292

1.38

1.24

1.2

1.3

143.31

296.37

u/l

0.39

210

Dermatitis and eczema

368

1.28

1.24

1.4

1.3

78.81

258.46

u/l

0.78

266

Other hearing loss

167

1.52

1.23

1.5

1.2

79.35

447.43

u/l

0.72

120

Sleep apnoea, including avohilmo

341

1.29

1.22

1.3

925.88

79.21

u/l

0.80

239

Insomnia

308

0.69

1.21

1.3

32.74

186.89

u/l

0.91

224

Hernia of abdominal wall

246

1.42

1.20

1.4

1.2

146.07

334.93

u/l

0.40

171

Benzodiazepine use

375

1.28

1.20

1.3

36.73

265.15

u/l

1.15

268

Diagnoses used for exclusion with ILD

148

1.55

1.19

1.3

1.2

205.94

278.08

u/l

0.11

103

Thyrotoxicosis

101

1.68

1.19

1.2

1.3

25.09

356.31

u/l

0.58

Acute upper respiratory infections of multiple and unspecified sites

270

1.34

1.17

1.3

42.76

205.69

u/l

0.83

200

Inflammatory bowel disease

133

1.58

1.17

1.4

1.3

38.27

348.69

u/l

0.80

101

Diaphragmatic hernia

206

1.46

1.17

1.3

83.90

395.30

u/l

0.72

143

Dental pulpitis, including avohilmo

280

0.70

1.16

1.1

1.3

70.61

323.70

u/l

0.88

205

Transient ischemic attack

282

1.35

1.16

1.3

33.46

166.06

u/l

0.70

212

Other contact dermatitis

0.00

1.16

0.0

1.4

—

950.88

—

Other neurotic disorders

2.50

1.15

1.6

1.3

30.20

1561.64

u/l

—

Struck by thrown, projected or falling objec

2.50

1.15

1.2

1.4

21.60

16.40

u/l

—

Inguinal hernia

233

1.35

1.13

1.4

1.3

111.94

347.73

u/l

0.58

170

Exposure to unspecified factor

377

1.28

1.13

1.3

127.08

246.61

u/l

0.41

271

Thyrotoxicosis, other and/or unspecified

1.75

1.12

1.3

27.75

396.01

u/l

—

Other bursopathies

1.90

1.12

1.2

1.3

32.52

605.93

u/l

—

Other abnormal uterine and vaginal bleeding

1.73

1.11

1.3

1.4

136.33

85.37

u/l

—

Other arthrosis

190

1.39

1.09

1.5

1.2

988.89

105.54

u/l

0.47

138

Chronic apical periodontitis

350

1.25

1.07

1.2

1.3

414.76

194.05

u/l

0.24

245

Erectile dysfunction

1.87

1.07

1.4

1.2

32.00

33.73

u/l

—

Mental and behavioural disorders due to psychoactive substance use

297

1.34

1.06

1.2

1.3

143.31

291.30

u/l

0.39

214

Ulcerative rectosigmoiditis

2.12

1.05

1.3

29.14

853.50

u/l

—

Postmenopausal atrophic vaginitis

0.44

1.05

1.4

534.32

64.79

u/l

—

Diabetic neuropathy

1.75

1.05

1.1

1.3

26.00

501.34

u/l

—

Congenital malformations, deformations and chromosomal abnormalities

217

1.40

1.04

1.5

1.2

64.54

234.49

u/l

0.63

160

Glaucoma suspect

212

1.42

1.03

1.3

21.44

204.78

u/l

0.68

150

Fracture at wrist and hand level

154

1.49

1.02

1.2

1.3

254.42

297.18

u/l

0.05

110

Coxarthrosis [arthrosis of hip](FG)

214

1.35

1.02

1.3

827.06

99.74

u/l

0.44

157

Open wound of head

287

1.34

1.01

1.3

782.17

199.97

u/l

0.35

207

Artificial joint operation, meniscal resection

357

1.25

1.01

1.3

590.53

168.58

u/l

0.37

256

Excessive, frequent and irregular menstruation

1.57

0.99

1.3

1.4

1763.93

78.17

u/l

0.53

Other fall from one level to another

1.62

0.99

1.1

1.3

2462.36

408.45

u/l

0.40

Other enthesopathies

123

1.55

0.99

1.8

1.3

48.65

312.53

u/l

0.60

Disorders of lacrimal system

205

1.41

0.99

1.1

1.3

1545.65

77.64

u/l

0.47

148

Other superficial mycoses

0.00

0.97

0.0

1.3

—

1049.71

—

Congenital malformations, deformations and chromosomal abnormalities

237

1.36

0.96

1.5

1.2

59.72

222.43

u/l

0.67

175

Benign neoplasm of brain and other parts of central nervous system

0.00

0.96

0.0

1.2

—

1072.00

—

Fracture of femur

157

1.44

0.95

1.1

1.2

70.36

274.94

u/l

0.47

104

Urticaria and erythema

141

1.49

0.94

1.2

1.3

29.33

292.09

u/l

0.69

107

Sleep disorders (combined)

335

1.22

0.90

1.3

880.14

79.23

u/l

0.80

239

Use of disulfiram, acamprosate or naltrexone

2.07

0.89

1.0

1.4

475.00

1071.63

u/l

—

Conjunctivitis (acute, non atopic)

110

1.54

0.89

1.5

1.3

2079.36

108.72

u/l

0.47

Arthrosis

204

1.29

0.88

1.3

1.2

36.26

117.88

u/l

1.55

150

Injuries to the elbow and forearm

292

1.29

0.87

1.3

768.10

91.55

u/l

0.47

207

Other diseases of stomach and duodenum

2.00

0.87

1.7

1.2

22.17

148.05

u/l

—

Other systemic involvement of connective tissue

128

1.49

0.85

1.2

2203.80

60.09

u/l

—

Lower back pain or/and sciatica

374

1.22

0.85

1.3

569.20

167.78

u/l

0.34

272

Benign neoplasm: Sigmoid colon

112

1.52

0.84

1.6

1.3

49.58

342.98

u/l

0.53

Alcoholic liver disease

1.76

0.83

1.3

50.40

498.72

u/l

—

Fracture of forearm

235

1.33

0.82

1.3

983.58

87.82

u/l

0.48

170

Fall on and from stairs and steps

121

1.49

0.82

1.3

1.2

134.85

350.81

u/l

0.39

Thyrotoxicosis with toxic multinodular goitre

1.88

0.81

1.5

1.3

28.33

1180.05

u/l

—

Melanocytic naevi of other and unspecified parts of face

0.00

0.79

0.0

1.1

—

1371.75

—

Oral lichen planus, including avohilmo , including avohilmo

0.00

0.79

0.0

1.3

—

1761.43

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

188

1.37

0.79

1.2

173.76

228.39

u/l

0.12

142

Progressive vascular leukoencephalopathy

0.00

0.79

0.0

1.2

—

21.47

—

Other and unspecified dermatitis

259

1.31

0.79

1.4

1.3

34.57

331.65

u/l

0.97

183

Use of selegiline

0.00

0.79

0.0

1.1

—

18.06

—

Other noninflammatory disorders of vagina

0.00

0.79

0.0

1.4

—

32.00

—

Sciatica+with lumbago

214

1.33

0.79

1.4

1.2

57.99

240.92

u/l

0.64

148

Other diseases of urinary system

321

1.21

0.76

1.4

1.2

508.90

190.00

u/l

0.31

229

Dislocation, sprain and strain of joints and ligaments of knee

216

1.32

0.75

1.3

92.95

221.87

u/l

0.44

166

Disorders of eyelid, lacrimal system and orbit

360

1.22

0.75

1.1

1.3

1295.36

76.91

u/l

0.78

263

Benign neoplasm of other and ill-defined parts of digestive system

1.52

0.75

1.1

1.3

3276.38

369.63

u/l

—

Gonarthrosis,primary

348

1.20

0.73

1.3

533.94

167.39

u/l

0.33

246

Acute sinusitis

194

1.34

0.73

1.3

53.29

251.13

u/l

0.73

150

Mental and behavioural disorders due to alcohol

269

1.29

0.73

1.2

1.3

165.30

324.72

u/l

0.36

190

Traumatic subdural haemorrhage

1.62

0.72

1.7

1.2

187.67

58.87

u/l

—

Carpal tunnel syndrome

255

1.28

0.72

1.3

1077.96

190.86

u/l

0.45

183

Meniscus derangement

194

1.28

0.71

1.3

1.2

1019.20

103.11

u/l

0.45

142

Alzheimer’s disease (Late onset)

144

0.64

0.71

1.1

1.2

36.40

299.82

u/l

—

Visual disturbances and blindness

274

1.28

0.69

1.4

1.3

205.27

306.45

u/l

0.20

194

Sequelae of cerebrovascular disease

213

1.30

0.69

1.2

1.3

74.87

189.27

u/l

0.38

160

Fall on same level involving ice and snow

292

1.27

0.69

1.3

35.04

302.40

u/l

1.01

209

Radiculopathy

1.53

0.68

1.1

1.3

27.16

423.33

u/l

—

Benign neoplasm of bone and articular cartilage

1.85

0.68

1.0

1.1

29.02

1157.84

u/l

—

Unspecified mental disorder

161

1.37

0.67

1.1

1.3

25.30

304.13

u/l

0.85

118

Other symptoms and signs involving cognitive functions and awareness

267

1.26

0.66

1.2

1.3

63.87

194.53

u/l

0.57

197

Open wound of forearm

1.59

0.65

1.3

1.2

92.00

24.06

u/l

—

Dermatophytosis

327

0.76

0.65

1.4

1.3

321.07

267.67

u/l

0.08

239

Keratitis

154

1.36

0.64

1.2

1955.21

286.72

u/l

0.43

114

Fracture of skull and facial bones

1.47

0.64

1.3

135.79

124.66

u/l

—

Use of levodopa decarbox-comt-inhibitor

0.00

0.60

0.0

1.2

—

16.67

—

Disorders of refraction and accommodation

1.45

0.60

1.4

1.3

204.00

402.25

u/l

—

Other and unspecified degenerative diseases of nervous system

0.00

0.60

0.0

1.1

—

18.13

—

Fibromyalgia

0.00

0.60

0.0

1.3

—

1752.36

—

Other disorders of bone

1.50

0.59

1.4

1.3

29.22

475.71

u/l

—

Other intracranial haemorrhages

0.00

0.59

0.0

1.1

—

21.47

—

Fracture of shoulder and upper arm

192

1.30

0.58

1.5

1.2

56.58

257.36

u/l

0.66

137

severe traumatic brain injury, does not include concussion

140

1.36

0.58

1.5

1.3

111.82

318.27

u/l

0.41

Glaucoma

312

1.21

0.58

1.3

40.14

286.09

u/l

0.99

224

Other systemic involvement of connective tissue (FG)

113

1.40

0.57

1.1

1.3

2446.11

81.16

u/l

—

N06DA Anticholinesterases

209

0.75

0.57

1.3

1.2

42.42

386.62

u/l

0.85

143

Use of anticholinesterases

209

0.75

0.57

1.3

1.2

42.42

386.62

u/l

0.85

143

Other disorders of lacrimal gland

167

1.32

0.56

1.1

1.3

1747.27

87.54

u/l

0.47

123

Chronic diseases of tonsils and adenoids

224

0.79

0.56

1.3

53.75

230.02

u/l

0.70

165

Caries of dentine, including avohilmo

255

1.18

0.55

1.3

532.37

111.32

u/l

0.39

174

Cervicobrachial syndrome

1.44

0.55

1.2

1.3

3197.75

445.01

u/l

—

Benign neoplasm: Colon, unspecified

159

1.32

0.55

1.8

1.2

1716.74

278.26

u/l

0.39

112

Injuries to the hip and thigh

265

1.23

0.55

1.3

58.07

328.07

u/l

0.85

185

Alzheimer’s disease, strict definition

150

0.71

0.53

1.2

35.57

289.40

u/l

—

Any mental disorder

312

1.16

0.52

1.3

95.89

282.38

u/l

0.63

225

Voice disturbances

126

1.35

0.51

1.4

1.3

119.30

298.97

u/l

—

Primary open-angle glaucoma

207

0.75

0.51

1.3

30.82

205.63

u/l

0.60

144

Other specific joint derangements/joint disorders

202

1.22

0.51

1.3

1.2

73.65

119.63

u/l

0.48

147

Menorrhagia

1.37

0.51

1.1

1.4

27.30

79.13

u/l

—

263

1.22

0.50

1.3

34.76

314.86

u/l

0.91

184

Coxarthrosis

195

1.22

0.50

1.3

1.2

940.18

102.35

u/l

0.44

144

Delivery

0.71

0.48

1.3

3475.43

62.07

u/l

—

D07AA Corticosteroids, weak (group I)

1.43

0.46

1.6

1.3

23.29

663.05

u/l

—

Retinal breaks without detachment

0.62

0.45

1.8

1.2

44.80

431.41

u/l

—

Disorders of synovium and tendon

215

1.22

0.45

1.5

1.3

170.10

221.54

u/l

0.10

153

Pain in joint

156

1.23

0.44

1.3

1.2

67.16

60.70

u/l

0.07

111

Medicines for HER+ breast cancer

131

1.30

0.44

1.3

33.38

328.58

u/l

0.64

Persons encountering health services for other counselling and medical advice, not elsewhere classified

345

1.13

0.44

1.2

1.3

31.54

173.90

u/l

0.92

242

Dentofacial anomalies [including malocclusion]

221

0.80

0.44

1.4

1.3

30.13

238.30

u/l

0.93

168

Seborrhoeic keratosis

130

1.31

0.43

1.4

1.2

51.22

282.94

u/l

—

Outcome of delivery

0.00

0.42

0.0

1.3

—

22.73

—

Dental caries, including avohilmo

249

1.15

0.42

1.3

556.78

112.95

u/l

0.39

170

Visual disturbances

249

1.21

0.41

1.4

1.3

232.32

324.09

u/l

0.16

182

Eating disorders

0.00

0.41

0.0

1.1

—

2425.67

—

Neurotic, stress-related and somatoform disorders

277

1.16

0.41

1.3

32.59

203.25

u/l

0.91

202

Spontaneous abortion

1.30

0.41

1.0

1.4

59.45

433.06

u/l

0.57

Macular cyst

0.00

0.40

0.0

1.1

—

21.55

—

Sixth [abducent] nerve palsy

0.00

0.40

0.0

1.1

—

16.17

—

Dislocation, sprain and strain of joint and ligaments of hip

0.00

0.40

0.0

1.1

—

17.36

—

Anxiety disorders

283

1.16

0.40

1.3

32.06

200.68

u/l

0.92

205

Exclusions for E4_PCOS_CONSORTIUM

167

1.20

0.40

1.3

30.61

245.55

u/l

0.65

124

Suppurative and unspecified otitis media

101

1.32

0.40

1.7

1.3

74.44

119.03

u/l

—

Use of ropinirole

0.00

0.40

0.0

1.2

—

17.42

—

Vascular dementia (mixed)

0.00

0.39

0.0

1.2

—

19.42

—

Unspecified/other endometriosis

0.00

0.39

0.0

1.5

—

30.62

—

Superficial injury of head

106

1.32

0.39

1.1

1.3

327.22

66.74

u/l

—

Other degenerative diseases of the nervous system

1.28

0.38

1.2

31.09

60.58

u/l

1.10

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

1.35

0.37

1.0

1.4

22.20

920.74

u/l

—

Headache

187

1.20

0.36

1.5

1.3

82.26

248.91

u/l

0.48

134

Persons encountering health services in other circumstances, wide

347

1.11

0.36

1.2

1.3

495.10

173.31

u/l

0.34

243

Disorders of the thyroid gland

341

1.13

0.36

1.2

1.3

86.84

257.36

u/l

0.60

246

Coxarthrosis, primary, with hip surgery

300

0.84

0.35

1.3

33.85

179.02

u/l

0.78

211

Psychiatric diseases

286

1.12

0.34

1.2

1.3

101.92

302.30

u/l

0.62

208

Alzheimer disease, including avohilmo

203

0.83

0.34

1.2

1.3

39.50

399.68

u/l

0.86

138

Diseases of the ear and mastoid process

301

1.12

0.34

1.3

460.88

93.23

u/l

0.41

223

Actinic keratosis

254

1.17

0.33

1.3

35.95

322.13

u/l

0.89

177

Coxibs

0.78

0.33

1.1

1.3

23.87

87.45

u/l

—

Hypothyroidism, strict autoimmune

229

1.15

0.33

1.3

103.79

215.58

u/l

0.29

169

Leiomyoma of uterus

129

1.19

0.31

1.2

1.3

35.37

331.23

u/l

0.67

Degenerative diseases of the nervous system

201

0.84

0.31

1.2

1.3

37.15

395.96

u/l

0.87

139

Hypothyroidism, other/unspecified

311

1.12

0.31

1.2

1.3

93.56

276.07

u/l

0.58

223

Viral warts

1.31

0.30

1.3

47.80

415.92

u/l

—

Extrapyramidal and movement disorders

239

0.84

0.29

1.3

42.85

342.17

u/l

0.89

171

Hypothyroidism, strict autoimmune, 3 medication purchases required

298

0.88

0.29

1.3

129.73

284.91

u/l

0.42

212

Skin changes due to chronic exposure to nonionizing radiation

257

1.15

0.28

1.3

35.95

322.71

u/l

0.90

179

Disorders of vitreous body

291

0.86

0.27

1.3

28.79

309.83

u/l

1.05

204

Organic, including symptomatic, mental disorders

266

1.12

0.27

1.1

1.3

37.07

300.32

u/l

0.90

194

Hypothyreosis and Thyroxine purchase for inclusion criteria

320

1.11

0.27

1.2

1.3

112.20

271.69

u/l

0.49

227

Nonsuppurative otitis media

0.67

0.26

1.4

1.3

138.80

81.79

u/l

—

Symptoms and signs involving speech and voice

169

1.18

0.25

1.3

1.2

103.33

257.12

u/l

0.37

123

Noninflammatory disorders of female genital tract

0.79

0.25

1.3

1.4

4080.17

78.17

u/l

—

Persons encountering health services in circumstances related to reproduction

139

1.16

0.24

1.2

1.3

31.92

334.25

u/l

0.82

106

Disorders of vitreous body and globe

296

0.88

0.24

1.3

28.79

307.54

u/l

1.06

206

Chronic sinusitis

191

0.84

0.24

1.4

1.2

82.00

245.96

u/l

0.49

139

Hallux valgus (acquired)

114

0.82

0.23

2.1

1.2

42.13

68.98

u/l

—

Anxiety disorders, excluding more controls

265

1.10

0.23

1.3

32.03

325.85

u/l

1.01

189

Chronic periodontitis, complicated

323

0.89

0.22

1.3

31.30

285.52

u/l

1.09

231

Melanocytic naevi

124

0.81

0.21

1.7

1.3

50.60

298.95

u/l

—

Carcinoma in situ of skin, other sites/unspecified

0.00

0.21

0.0

1.0

—

13.60

—

Disorders of optic nerve, not elsewhere classified

0.00

0.21

0.0

1.0

—

15.83

—

Communicating hydrocephalus

0.00

0.21

0.0

1.0

—

16.50

—

Erythema intertrigo

0.00

0.21

0.0

1.0

—

14.80

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

0.00

0.21

0.0

1.0

—

14.80

—

Other and unspecified injuries of shoulder and upper arm

0.00

0.21

0.0

1.1

—

16.50

—

Convergent concomitant strabismus

0.00

0.21

0.0

1.0

—

3106.00

—

Papulosquamous disorders

201

1.14

0.21

1.0

1.3

163.38

220.22

u/l

0.13

155

Tuberculosis of other organs

0.00

0.21

0.0

1.0

—

16.75

—

Prurigo nodularis

0.00

0.21

0.0

1.0

—

2722.00

—

Other disorders of eyelid

264

1.12

0.20

1.2

1.3

87.15

71.07

u/l

0.13

188

Complications following abortion and ectopic and molar pregnancy

0.00

0.20

0.0

1.4

—

3067.38

—

Other obstructive and reflux uropathy

0.00

0.20

0.0

1.1

—

18.00

—

Excessive vomiting in pregnancy

0.00

0.20

0.0

1.4

—

3071.00

—

Other disorders of veins

182

1.15

0.20

1.4

1.2

82.20

98.91

u/l

0.11

132

Nontoxic multinodular goitre

1.21

0.19

1.1

1.3

33.43

354.78

u/l

—

Diseases of pulp and periapical tissues, including avohilmo

318

1.07

0.19

1.2

1.3

477.61

200.84

u/l

0.27

219

Dementia in Alzheimer disease

103

0.82

0.18

1.0

1.2

41.00

81.76

u/l

—

Other diseases of lip and oral mucosa

196

0.87

0.18

1.1

1.3

104.75

235.67

u/l

0.36

148

Use of other anti-dementia drugs

161

1.13

0.17

1.2

1.3

40.62

274.19

u/l

0.57

104

Use of memantine

161

1.13

0.17

1.2

1.3

40.62

274.19

u/l

0.57

104

Ulcerative colitis (strict definition, all Crohn cases excluded)

1.13

0.17

1.3

27.00

534.92

u/l

—

Selective serotonin reuptake inhibitors

308

0.93

0.17

1.3

1.2

46.66

302.83

u/l

0.98

215

Female infertility, cervical, vaginal, other or unspecified origin

1.13

0.16

1.0

1.4

77.63

75.00

u/l

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

0.86

0.16

1.2

1.3

29.79

88.40

u/l

0.47

Gingivitis and periodontal diseases

325

0.94

0.16

1.2

1.3

579.23

201.32

u/l

0.31

231

Excessive earwax

323

1.09

0.16

1.1

1.3

832.93

188.90

u/l

0.36

227

Unspecific neurodegenerative disorder

225

0.91

0.16

1.2

1.3

36.94

350.09

u/l

0.86

159

Atopic dermatitis, strict definition

0.76

0.15

2.5

1.3

41.67

503.30

u/l

—

5-aminosalicylic acid

1.13

0.15

1.3

24.56

175.84

u/l

—

Depression or dysthymia

227

0.92

0.15

1.3

1.2

147.60

372.34

u/l

0.49

161

Psoriasis

140

1.14

0.15

1.0

1.3

104.70

311.61

u/l

—

105

Myocardial infarction, with ST-elevation

129

0.85

0.14

1.5

1.2

54.20

305.72

u/l

—

Primary gonarthrosis, bilateral

285

1.08

0.14

1.3

941.86

190.28

u/l

0.40

198

Disorders of conjunctiva

320

0.93

0.14

1.5

1.3

1770.32

82.56

u/l

0.80

225

Spondylosis

240

0.92

0.13

1.1

1.3

1385.37

217.80

u/l

0.40

170

Gonarthrosis, primary, with knee surgery

308

0.93

0.13

1.3

945.73

177.02

u/l

0.41

216

Other joint disorders

212

1.07

0.12

1.2

39.18

115.10

u/l

1.44

155

Colonic or urogenital fistula

127

0.87

0.12

1.2

1.3

37.00

330.12

u/l

—

Pregnancy with abortive outcome

121

0.91

0.12

1.0

1.3

33.54

342.52

u/l

0.63

Diseases of middle ear and mastoid

188

1.09

0.11

1.5

1.2

1413.44

108.74

u/l

0.46

137

Acetic acid derivatives and related substances

1.10

0.11

1.1

1.3

1489.81

87.45

u/l

0.46

Lung diseases due to external agents

1.16

0.11

1.0

1.2

18.60

461.26

u/l

—

Blepharochalasis

173

1.10

0.10

1.3

95.33

58.36

u/l

0.21

127

Mucosal proctocolitis

1.06

0.09

1.8

1.4

23.80

679.76

u/l

—

Burns and corrosions of external body surface, specified by site

1.04

0.09

1.0

1.3

4348.00

28.74

u/l

—

Other sleep disorders

1.04

0.09

1.0

1.3

5090.00

37.37

u/l

—

Alzheimer disease

174

0.92

0.09

1.2

38.67

249.51

u/l

0.58

116

In situ neoplasms

223

1.08

0.09

1.1

1.2

72.71

192.26

u/l

0.37

152

Conjunctivitis

275

0.94

0.09

1.5

1.2

964.64

89.51

u/l

0.49

198

Atrophic disorders of skin

1.05

0.08

2.8

1.2

38.33

628.06

u/l

—

Retinal detachments and breaks

214

1.07

0.08

1.2

1.3

107.71

380.23

u/l

0.65

154

Diseases of external ear

175

1.09

0.08

1.2

64.86

453.29

u/l

0.82

125

Other disorders of patella

0.82

0.08

1.2

1.3

38.40

191.15

u/l

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

1.06

0.08

1.3

25.71

504.98

u/l

—

Benign neoplasm: Caecum

1.04

0.08

1.6

1.3

403.86

486.69

u/l

—

Ulcerative colitis (strict definition, require KELA)

1.03

0.07

1.3

25.71

495.73

u/l

—

Female infertility

1.06

0.07

1.0

1.4

77.63

75.00

u/l

—

Diseases of inner ear

306

0.95

0.07

1.4

1.3

1185.41

181.33

u/l

0.40

213

Diverticular disease of intestine

267

0.96

0.07

1.5

1.3

29.45

307.00

u/l

1.03

202

IBD patients in KELA-register

1.06

0.07

1.3

26.56

493.00

u/l

—

Injuries to the wrist and hand

374

1.04

0.07

1.2

1.3

871.40

150.63

u/l

0.48

275

Primary coxarthrosis, bilateral

187

1.07

0.06

1.2

1841.85

221.51

u/l

0.41

129

Disorders of skin appendages

203

0.93

0.06

1.5

1.3

37.09

239.22

u/l

0.78

154

Benign paroxysmal vertigo

158

1.08

0.06

1.5

1.2

2143.67

252.07

u/l

0.41

111

Anti-inflammatory and antirheumatic products, non-steroids

1.07

0.05

1.2

1.3

20.87

87.45

u/l

0.58

Zoster [herpes zoster]

282

1.05

0.05

1.2

1.3

37.57

298.09

u/l

0.90

196

Nontoxic goitre/thyroid nodule

139

1.08

0.05

1.2

313.00

273.71

u/l

—

Other diseases of hard tissues of teeth

189

1.04

0.05

1.3

863.62

89.30

u/l

0.51

124

Disorders of vestibular function (Vertigo)

268

0.95

0.05

1.4

1.3

1300.51

193.05

u/l

0.40

188

Ovarian cyst

1.09

0.04

1.2

1.4

50.29

63.36

u/l

—

Excessive attrition of teeth

241

0.95

0.04

1.2

1.3

45.27

218.63

u/l

0.80

183

Fissure and fistula of anal and rectal regions

101

1.09

0.04

1.2

37.00

356.52

u/l

—

Disorders of breast

145

0.94

0.04

1.1

1.3

19.78

296.42

u/l

—

102

Other extrapyramidal and movement disorders in other diseases

129

0.93

0.03

1.4

1.3

29.43

295.83

u/l

—

Artrosis, including avohilmo

272

1.03

0.03

1.3

33.61

213.85

u/l

0.91

192

Open wound of wrist and hand

205

0.95

0.03

1.4

1.3

1916.07

228.02

u/l

0.47

149

Mood disorders

351

0.98

0.03

1.3

55.56

285.18

u/l

0.99

243

Depression

324

1.02

0.03

1.3

57.85

296.97

u/l

0.94

226

All anxiety disorders

173

0.96

0.02

1.2

1.3

29.53

288.04

u/l

0.84

126

Mood [affective] disorders

350

0.98

0.02

1.3

55.56

283.33

u/l

0.97

242

Injuries to the shoulder and upper arm

387

1.02

0.02

1.4

1.3

44.82

258.66

u/l

1.07

273

Chronic periodontitis, including avohilmo

375

0.98

0.02

1.3

583.26

182.32

u/l

0.32

269

Coxarthrosis, primary

346

0.98

0.02

1.3

876.42

162.00

u/l

0.41

242

Any dementia, excluding more controls

191

0.97

0.01

1.1

1.2

40.35

390.36

u/l

0.80

134

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

116

0.95

0.00

1.1

1.3

165.17

356.88

u/l

—

Ventral hernia

124

1.05

0.00

1.5

1.3

457.00

311.70

u/l

—

Diseases of pulp and periapical tissues and dental caries

227

1.02

0.00

1.3

658.86

106.99

u/l

0.42

154

Viral infections characterized by skin and mucous membrane lesions

385

1.00

0.00

1.3

143.03

246.41

u/l

0.28

276

Mood disorders, excluding more controls

299

1.00

0.00

1.3

57.43

296.07

u/l

0.87

213

Exposure to other specified factors

335

1.01

0.00

1.2

1.3

1626.07

88.02

u/l

0.77

232

Periodontitis

374

1.00

0.00

1.3

570.17

182.77

u/l

0.31

268

Inflammatory diseases of female pelvic organs

143

0.98

0.00

1.2

1.3

42.19

301.47

u/l

0.62

Complications of labour and delivery

104

1.02

0.00

1.2

1.3

47.04

367.74

u/l

0.60

Anxiety (asthma-related co-morbidities)

160

1.01

0.00

1.2

1.3

29.53

279.01

u/l

0.75

119

Any dementia

213

1.01

0.00

1.1

1.3

38.00

371.48

u/l

0.86

149

Dementia, including avohilmo

246

1.01

0.00

1.1

1.3

38.54

320.51

u/l

0.87

178

Dementia

232

1.01

0.00

1.1

1.3

37.82

337.26

u/l

0.88

168

Mycoses

387

1.01

0.00

1.4

1.3

1015.23

161.21

u/l

0.50

282

Alzheimer disease, excluding more controls

0.98

0.00

1.2

1.1

35.67

70.63

u/l

—

Benign lipomatous neoplasm of other sites/unspecified

0.94

0.00

1.2

1.3

31.82

646.00

u/l

—

Complications predominantly related to the puerperium

0.97

0.00

1.8

1.3

25.83

592.43

u/l

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

0.97

-0.00

1.3

25.71

478.73

u/l

—

Inflammatory bowel disease, strict (require KELA)

1.01

-0.00

1.3

26.56

481.73

u/l

—

0.00

-0.00

0.0

1.2

—

20.00

—

Burns and corrosions

1.02

-0.00

1.0

1.3

3626.17

31.98

u/l

—

Mumps

0.00

-0.00

0.0

1.0

—

15.00

—

Other maltreatment syndromes

0.00

-0.00

0.0

1.0

—

13.00

—

Other superficial mycoses

0.00

-0.00

0.0

1.0

—

15.40

—

Benign neoplasm: Skin of other and unspecified parts of face

1.00

-0.00

1.5

1.3

32.00

578.00

u/l

—

Parapsoriasis

0.00

-0.00

0.0

1.0

—

15.00

—

Childhood allergy (age < 16)

0.00

-0.00

0.0

1.6

—

29.20

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Amylase [Enzymatic activity/volume] in Pleural fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS